Stop TB Partnershipのアドボカシー・コミュニケーション活動について、概要、成果、課題をまとめています。（2009/08/09）

1. Ｓｔｏｐ ＴＢ Ｐａｒｔｎｅｒｓｈｉｐの
アドボカシー・コミュニケーション
活動について
1. 概要
2. 成果
3. 課題
鈴木幹久

2. Key events in the establishment of the
Global Stop TB Partnership
• 1991: WHA resolution set TB control targets for 2000; targets later postponed to 2005.
• 1993: WHO declared TB a global health emergency.
• 1996: TB Diagnostics Initiative created.
• 1998: Report of the Ad Hoc Committee on the TB Epidemic.
• Stop TB Initiative for Global Action campaign launched.
• 1999: Working Group on DOTS-Plus for MDR TB set up;
• Green Light Committee established as its subgroup in 2000.
• March 2000: Ministerial Conference on TB and Sustainable Development (20 countries), leading to
• the Amsterdam Declaration to Stop TB
• 2000 Stop TB Partnership established
• 2000: Global Alliance for TB Drug Development established.
• 1st meeting of DOTS Expansion Working Group.
• Feb 2001: Stop TB (Interim) Coordinating Board meeting, Bellagio.
• 2001: Global TB Drug Facility (GDF) established.
• 2001: TB-HIV Working Group established.
• Global TB Vaccine Forum established.
• 2001: Global DOTS Expansion Plan
• October 2001: 1st Stop TB Partners’

3. Mission
To increase access, security and support to:
• ensure that every TB patient has access to TB treatment and cure
• stop transmission of TB
• protect vulnerable populations from TB
• reduce the social and economic toll that TB exerts on families, communities and nations.
Targets
• By 2005: 70% of people with infectious TB will be diagnosed, and 85% cured.
• By 2010: the global burden of TB disease (deaths and prevalence) will be reduced by 50%
(compared with 2000 levels).
• By 2050: the global incidence of TB disease will be less than 1 per million population.
MDG TB-related Target and Indicators
• Target 8: By 2015, to have halted and begun to reverse the incidence of malaria and other
major diseases.
• Indicator 23: prevalence and death rates associated with tuberculosis
• Indicator 24: proportion

4. Stop TB Partners
• Non-governmental organisations
• Governmental organisations
• Intergovernmental organisations
• Academic institution
• For profit organisation
• Others
Total 1041

5. Board Composition
• 4 representatives from high burden countries,
• 3 representatives, one from each of WHO, the World Bank and the GFATM ,
• 1 representative of another international organization,
• 6 regional representatives, assuring the inclusion of representatives from non-high
burden countries,
• 7 Working Group Chairpersons representing DOTS Expansion, MDR-TB, TB-HIV,
Diagnostics, TB Drug Development, New Vaccines and Global Laboratory Initiative,
• 5 representatives of financial donors,
• 1 representative of Foundations,
• 3 representatives of NGOs and technical agencies, including The Union and CDC as
permanent members,
• 2 representatives of communities affected by TB,
• The Chair of the WHO STAG, and 1 representative of the corporate business sector

7. アドボカシー活動
ストップ結核パートナーシップ推進議員
連盟が発足、STBJをサポートしている。
7
コミュニケーション活動
・マンガコンペを開催。日本からは 麻生太郎氏
が審査委員として参加
・ビートたけし氏をストップ結核大使に任命

8. Independent Evaluation of the Stop TB Partnership (2008 McKinsey & Company)

9. Independent Evaluation of the Stop TB Partnership (2008 McKinsey & Company)

10. Independent Evaluation of the Stop TB Partnership (2008 McKinsey & Company)

11. Independent Evaluation of the Stop TB Partnership (2008 McKinsey & Company)

12. ストップ結核ジャパンアクションプランを発表
• 外務省、厚生労働省、JICA、結核予防会と協働で立案
• 166万人亡くなっている結核患者の1割を救済する「10％
宣言」が盛り込まれる
12
国際結核シンポジウムにて発表
（2008年7月、国連大学）

13. Independent Evaluation of
the Stop TB Partnership
(2008 McKinsey & Company)
“The Partnership comes under increasing
pressure, particularly from donors, to merge
into a larger, trans-disease partnership that can
support the wider agenda and reduces
transaction costs for recipient governments .”

14. International Health Partnership
launched in London in 2007.
• UK, Norway, Germany, Canada, Italy, The Netherlands, France and
Portugal
• Burundi, Cambodia, Ethiopia, Kenya, Mozambique, Nepal and
Zambia
• WHO, European Union, World Bank, UNAIDS, UNFPA, GAVI, UNICEF,
Gates Foundation, African Development Bank and the Global fund
to Fight AIDS, TB and Malaria
• focusing on improving health systems as a whole rather than on
individual diseases or issues;
• bringing about better coordination of effort among donors;
• developing and supporting the health plans of recipient countries.

15. How effective are Intergovernmental
Organisations in controlling their spread?
1st Report, Select Committee on Intergovernmental Organisations,
House of Lords, 21 July 2008
• “We recommend also that the IHP should be developed in a way which
simplifies and avoids complicating further the already complex global
health governance picture.”
• “We do not suggest that the UK should simply replicate the Swiss
arrangements for global health policy formulation. Nor do we have a
readymade solution to the problem to offer. We do, however, recommend
that the Government should take another look at the machinery for
coordinating UK policies with a view to ensuring that the interests of those
Whitehall departments who are closely involved with the international
dimension of global health are given their due weight and that this is
reflected in the arrangements for leadership of the Global Health
Strategy. ”